EGFR c.2267A>G ;(p.N756S)

Variant ID: 7-55242497-A-G

NM_005228.3(EGFR):c.2267A>G;(p.N756S)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Landscape of drug-resistance mutations in kinase regulatory hotspots.

Briefings In Bioinformatics
Kim, Pora P; Li, Hanyang H; Wang, Junmei J; Zhao, Zhongming Z
Publication Date: 2021-05-20

Variant appearance in text: EGFR: N756S
PubMed Link: 32510566
Variant Present in the following documents:
  • Main text
View BVdb publication page



Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Publication Date: 2018

Variant appearance in text: EGFR: N756S
PubMed Link: 29698444
Variant Present in the following documents:
  • pone.0196434.s001.xlsx, sheet 3
  • pone.0196434.s001.xlsx, sheet 1
View BVdb publication page



Assessment of computational methods for predicting the effects of missense mutations in human cancers.

Bmc Genomics
Gnad, Florian F; Baucom, Albion A; Mukhyala, Kiran K; Manning, Gerard G; Zhang, Zemin Z
Publication Date: 2013

Variant appearance in text: EGFR: N756S
PubMed Link: 23819521
Variant Present in the following documents:
  • 1471-2164-14-S3-S7-S1.xlsx, sheet 1
View BVdb publication page



Mutations of the EPHB6 receptor tyrosine kinase induce a pro-metastatic phenotype in non-small cell lung cancer.

Plos One
Bulk, Etmar E; Yu, Jun J; Hascher, Antje A; Koschmieder, Steffen S; Wiewrodt, Rainer R; Krug, Utz U; Timmermann, Bernd B; Marra, Alessandro A; Hillejan, Ludger L; Wiebe, Karsten K; Berdel, Wolfgang E WE; Schwab, Albrecht A; Müller-Tidow, Carsten C
Publication Date: 2012

Variant appearance in text: EGFR: 2267A>G
PubMed Link: 23226491
Variant Present in the following documents:
  • Main text
View BVdb publication page



Variability in organ-specific EGFR mutational spectra in tumour epithelium and stroma may be the biological basis for differential responses to tyrosine kinase inhibitors.

British Journal Of Cancer
Weber, F F; Fukino, K K; Sawada, T T; Williams, N N; Sweet, K K; Brena, R M RM; Plass, C C; Caldes, T T; Mutter, G L GL; Villalona-Calero, M A MA; Eng, C C
Publication Date: 2005-05-23

Variant appearance in text: EGFR: N756S
PubMed Link: 15841079
Variant Present in the following documents:
  • Main text
  • 92-6602557a.pdf
View BVdb publication page